9 Meters Biopharmaincis A Clinical Stage Biopharmaceutical Company Based In Raleighnorth Carolinathe Company Focuses On Developing Treatments For Rare Gastrointestinal Disordersit Was Formed Through The Merger Of Innovate Biopharmaceuticals And Rdd Pharma In April 2020Followed By The Acquisition Of Naia Rare Diseases In May 20209 Meters Biopharma Is Publicly Traded On Nasdaq Under The Ticker Symbol Nmtr The Company Has A Diverse Product Pipeline That Includes Nm 002Vurolenatidelarazotidenm 003Nm 102And Nm 136Targeting Various Gastrointestinal Conditions And Related Disorders9 Meters Biopharma Has Also Established Partnerships And Licensing Agreements With Several Organizations To Support Its Development Efforts
No conferences found for this company.
| Company Name | 9 Meters Biopharma Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
